Separate analysis conducted in tumors and non-cancerous adjacent tissue showed that IL32 expression significantly increased along with growing depth of tumor invasion (T stage) in ESCC patients in adjacent tissue but not in tumors: (ρ = 0.51, p = 0.036). The gene discussed is IL32; the disease is neoplasm.